Search Results - Michela Verzè, MSc

BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature by Marianna Peroni, MD, Alessandro Leonetti, MD, PhD, Roberta Minari, MSc, PhD, Michela Verzè, MSc, Letizia Gnetti, MD, Lorena Bottarelli, MSc, PhD, Cinzia Azzoni, MSc, PhD, Marco Galaverni, MD, Nicola Simoni, MD, Gabriele Missale, MD, Elisabetta Biasini, MD, Marcello Tiseo, MD, PhD

Get full text